HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Synaptogenix Announces $5.0 Million Financing
"We are pleased to benefit from the support of our committed long-term investors in this financing," said Dr. Alan Tuchman, Chief Executive Officer of Synaptogenix. "This capital enhances our ability to be both strategic and opportunistic as we explore potential acquisitions or fund research on innovative assets, all with the goal of driving growth and maximizing value for our shareholders."
Syantra Secures $4.9 Million in Series A-1 Funding; Adds Dr. Rick Mangat to Board of Directors
Syantra secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer
XII Medical Raises $45 Mil in Series B Financing
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.
Apheros Secures $1.85M
Apheros notes the pre-seed funding round, led by venture capital firm Founderful, will accelerate development and deployment of the companys' revolutionary metal foam-based cooling solutions.
MolecuLight Secures $11.7 Million in Financing to Accelerate Global Expansion
"MolecuLight's innovative technology has the potential to significantly improve patient outcomes and offers compelling benefits for all healthcare system stakeholders," said Guillermo Freire, Senior Vice-President, Mid-Market Group, EDC. "We are excited to invest in MolecuLight as they accelerate commercialization. EDC is focused on supporting emerging Canadian innovators in critical sectors essential for the future. This investment reflects our belief in innovation and progress, underscoring mission is to support Canadian companies in their journey to become international leaders in their sectors."
Prolific Machines Receives Grant to Develop a Platform to Produce Affordable Monoclonal Antibodies to Prevent Infectious Disease in Low- and Middle-Income Countries
Prolific Machines will apply its optogenetics expertise to enable reproducible biomanufacturing solutions that create global access to life-saving drugs for vulnerable populations in low- and middle-income countries (LMICs).
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer’s Disease
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round
The landmark investment in dental artificial intelligence enables Pearl to further expand its dental AI solutions and meaningfully improve oral health outcomes for patients.
Samsung Ventures Among Top Investors Backing AI Imaging Acquisition Market Leader Subtle Medical – Bringing Total Series B to Over $30 Million
The funds will primarily support accelerating US and global sales initiatives and expediting the launch of new AI-driven products notes Subtle Medical.
